Ivashchenko AA - Search Results

1

AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial.

Ivashchenko AA, Dmitriev KA, Vostokova NV, Azarova VN, Blinow AA, Egorova AN, Gordeev IG, Ilin AP, Karapetian RN, Kravchenko DV, Lomakin NV, Merkulova EA, Papazova NA, Pavlikova EP, Savchuk NP, Simakina EN, Sitdekov TA, Smolyarchuk EA, Tikhomolova EG, Yakubova EV, Ivachtchenko AV. Ivashchenko AA, et al. Clin Infect Dis. 2021 Aug 2;73(3):531-534. doi: 10.1093/cid/ciaa1176. Clin Infect Dis. 2021. PMID: 32770240 Free PMC article. Clinical Trial.

2

Property-based design of GPCR-targeted library.

Balakin KV, Tkachenko SE, Lang SA, Okun I, Ivashchenko AA, Savchuk NP. Balakin KV, et al. Among authors: ivashchenko aa. J Chem Inf Comput Sci. 2002 Nov-Dec;42(6):1332-42. doi: 10.1021/ci025538y. J Chem Inf Comput Sci. 2002. PMID: 12444729

3

Advanced exact structure searching in large databases of chemical compounds.

Trepalin SV, Skorenko AV, Balakin KV, Nasonov AF, Lang SA, Ivashchenko AA, Savchuk NP. Trepalin SV, et al. Among authors: ivashchenko aa. J Chem Inf Comput Sci. 2003 May-Jun;43(3):852-60. doi: 10.1021/ci025582d. J Chem Inf Comput Sci. 2003. PMID: 12767143

4

Classification scheme for the design of serine protease targeted compound libraries.

Lang SA, Kozyukov AV, Balakin KV, Skorenko AV, Ivashchenko AA, Savchuk NP. Lang SA, et al. Among authors: ivashchenko aa. J Comput Aided Mol Des. 2002 Nov;16(11):803-7. doi: 10.1023/a:1023832728547. J Comput Aided Mol Des. 2002. PMID: 12825792

5

Structure-based versus property-based approaches in the design of G-protein-coupled receptor-targeted libraries.

Balakin KV, Lang SA, Skorenko AV, Tkachenko SE, Ivashchenko AA, Savchuk NP. Balakin KV, et al. Among authors: ivashchenko aa. J Chem Inf Comput Sci. 2003 Sep-Oct;43(5):1553-62. doi: 10.1021/ci034114g. J Chem Inf Comput Sci. 2003. PMID: 14502489

6

In silico estimation of DMSO solubility of organic compounds for bioscreening.

Balakin KV, Ivanenkov YA, Skorenko AV, Nikolsky YV, Savchuk NP, Ivashchenko AA. Balakin KV, et al. Among authors: ivashchenko aa. J Biomol Screen. 2004 Feb;9(1):22-31. doi: 10.1177/1087057103260006. J Biomol Screen. 2004. PMID: 15006145

7

Kohonen maps for prediction of binding to human cytochrome P450 3A4.

Balakin KV, Ekins S, Bugrim A, Ivanenkov YA, Korolev D, Nikolsky YV, Skorenko AV, Ivashchenko AA, Savchuk NP, Nikolskaya T. Balakin KV, et al. Among authors: ivashchenko aa. Drug Metab Dispos. 2004 Oct;32(10):1183-9. doi: 10.1124/dmd.104.000356. Epub 2004 Jul 1. Drug Metab Dispos. 2004. PMID: 15231683

8

Quantitative structure-metabolism relationship modeling of metabolic N-dealkylation reaction rates.

Balakin KV, Ekins S, Bugrim A, Ivanenkov YA, Korolev D, Nikolsky YV, Ivashchenko AA, Savchuk NP, Nikolskaya T. Balakin KV, et al. Among authors: ivashchenko aa. Drug Metab Dispos. 2004 Oct;32(10):1111-20. doi: 10.1124/dmd.104.000364. Epub 2004 Jul 21. Drug Metab Dispos. 2004. PMID: 15269187

9

Comprehensive computational assessment of ADME properties using mapping techniques.

Balakin KV, Ivanenkov YA, Savchuk NP, Ivashchenko AA, Ekins S. Balakin KV, et al. Among authors: ivashchenko aa. Curr Drug Discov Technol. 2005 Jun;2(2):99-113. doi: 10.2174/1570163054064666. Curr Drug Discov Technol. 2005. PMID: 16472234

10

Efficient optimization strategy for marginal hits active against abl tyrosine kinases.

Tkachenko SE, Okun I, Balakin KV, Petersen CE, Ivanenkov YA, Savchuk NP, Ivashchenko AA. Tkachenko SE, et al. Among authors: ivashchenko aa. Curr Drug Discov Technol. 2004 Oct;1(3):201-10. doi: 10.2174/1570163043335018. Curr Drug Discov Technol. 2004. PMID: 16472247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page